Skip to main content
OpenTrials
Completed

NCT Number: NCT02266667

Surgical Treatment of Progressive Scoliosis With "NEMOST" Growing Rod

The purpose of this study is to evaluate the performance of the device "NEMOST" on maintaining of the correction of the scoliosis with growth preservation and avoiding iterative surgeries.

Objective of this study is to evaluate the performance of the growing device "NEMOST" associated to physiotherapy at 12 months postoperatively in patients treated for progressive scoliosis and to evaluate its safety.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Necker Enfants Malades

Paris, 75015, France

About this study

A number of scoliosis in the child remain progressive despite conservative treatment well conducted. Nowadays the most used treatment is early surgical treatment by the spinal instrumentation without graft called "growing rods". The use of growing rods in patients with progressive scoliosis requires several repeated surgeries (every 6 to 12 months) in order to follow the growth of children. These repeated surgeries lead to a significant increased risk of complications, that's why many teams around the world have been seeking solutions which allow to obtain a rod expansion without repeated surgery.

The purpose of our study is the evaluation of the use of medical device that will perform the correction of scoliosis and, at the same time, preserve the growth of the child's spine. In addition, the purpose of clinical investigation is to test the theory that distraction effort may be exercised without surgery thanks to traction manoeuvres and physiotherapy. This could allow to obtain in patients with progressive scoliosis, correction of spinal deformity while avoiding many repeated surgeries. Our reference device is growing rod "NEMOST". When implanted, NEMOST rod is immediately turned on, for correcting and maintaining the correction of spinal deformity. After implantation, depending on development in Cobb angle, one or more elongations can be made by sliding the notched portion of the rod in its tunnel by a distraction effort (traction equipments and physiotherapy).

Therefore, the growth device NEMOST will allow to continue, on request, the correction of spinal deformity by performing a distraction by external manoeuvres on the notched part without the need for surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient from 5 to 15 years old
  • Patient with neuromuscular scoliosis or progressive scoliosis resistant to conservative treatment
  • Patient with an indication of first-line surgery without graft
  • Patient with low skeletal maturity (Risser test = 0 and triradiate growth cartilages still open)
  • Signing of the consent by the holder (s) of parental authority and the investigator
  • Affiliated patient to a health service or entitled patient

Exclusion criteria

  • Patient with a history of spinal surgery
  • Patient weighing more than 30 kg and with progressive scoliosis other than neuromuscular
  • Patient with contra-indication to Nemost device, that is to say:
  • Inflammation or acute Infection, local or systemic,
  • Allergy or intolerance titanium or polyetheretherketone,
  • Pathology or poor bone quality might compromise the attachment of the device,
  • Nonreducible Scoliosis,
  • Skin Substance insufficient to cover the wound,
  • Pathological Obesity,
  • Fracture and / or spinal tumor,
  • Patient whose behavior presents a risk of failure for the device.

Treatment and study plan

2 NEMOST rods : bilateral vertebral-pelvic implantation

Device

Implantation of two NEMOST rods (bilateral vertebral-pelvic implantation)

1 NEMOST rod :unilateral vertebral-pelvic implantation

Device

Implantation of one NEMOST rod (unilateral vertebral-pelvic implantation)

Primary outcomes

  1. No surgical reoperation

    Time frame: 12 months

    The lack of indication of surgical reoperations means that the correction of scoliosis is satisfactory and the growth had been maintained

  2. No worsening of Cobb angle by more than 15 degrees since the initial correction

    Time frame: 12 months

    A worsening of the Cobb angle by more than 15 ° since the initial correction is considered an indication of reoperation

Secondary outcomes

  1. Cobb angle

    Time frame: 3 months

    Radiographic measure : less than 15 degrees since the initial correction

  2. Cobb angle

    Time frame: 6 months

    Radiographic measure : less than 15 degrees since the initial correction

  3. Cobb angle (degree)

    Time frame: 18 months

    Radiographic measure : less than 15 degrees since the initial correction

  4. reserve rod (mm)

    Time frame: 3 months

    This amount reflects the actual elongation of the device

  5. reserve rod (mm)

    Time frame: 6 months

    This amount reflects the actual elongation of the device

  6. reserve rod (mm)

    Time frame: 12 months

    This amount reflects the actual elongation of the device

  7. reserve rod (mm)

    Time frame: 18 months

    This amount reflects the actual elongation of the device

  8. T1-T12 segment and T1-S1 segment

    Time frame: 3 months

    which reflect the real growth of the spine

  9. T1-T12 segment and T1-S1 segment

    Time frame: 6 months

    which reflect the real growth of the spine

  10. T1-T12 segment and T1-S1 segment

    Time frame: 12 months

    which reflect the real growth of the spine

  11. T1-T12 segment and T1-S1 segment

    Time frame: 18 months

    which reflect the real growth of the spine

  12. respiratory function

    Time frame: 6 months

    Translated chest and lung growth, as well as the actual improvement of respiratory function

  13. respiratory function

    Time frame: 12 months

    Translated chest and lung growth, as well as the actual improvement of respiratory function

  14. respiratory function

    Time frame: 18 months

    Translated chest and lung growth, as well as the actual improvement of respiratory function

  15. Pelvic obliquity (mm)

    Time frame: 3 months

    translated improving the overall balance of the trunk of the patient for the group of children with neuromuscular scoliosis

  16. Pelvic obliquity (mm)

    Time frame: 6 months

    translated improving the overall balance of the trunk of the patient for the group of children with neuromuscular scoliosis

  17. Pelvic obliquity (mm)

    Time frame: 12 months

    translated improving the overall balance of the trunk of the patient for the group of children with neuromuscular scoliosis

  18. Pelvic obliquity (mm)

    Time frame: 18 months

    translated improving the overall balance of the trunk of the patient for the group of children with neuromuscular scoliosis

  19. Safety of NEMOST

    Time frame: 3 months

    Nature-incidence and severity of complications due to NEMOST : infections, elongation failure, problems with healing after surgery, neurological deficit) Nature and incidence of any medical and surgical intervention in relation to device NEMOST

  20. Safety of NEMOST

    Time frame: 6 months

    Nature-incidence and severity of complications due to NEMOST : infections, elongation failure, problems with healing after surgery, neurological deficit) Nature and incidence of any medical and surgical intervention in relation to device NEMOST

  21. Safety of NEMOST

    Time frame: 12 months

    Nature-incidence and severity of complications due to NEMOST : infections, elongation failure, problems with healing after surgery, neurological deficit) Nature and incidence of any medical and surgical intervention in relation to device NEMOST

  22. Safety of NEMOST

    Time frame: 18 months

    Nature-incidence and severity of complications due to NEMOST : infections, elongation failure, problems with healing after surgery, neurological deficit) Nature and incidence of any medical and surgical intervention in relation to device NEMOST

  23. Weight (kg)

    Time frame: Every month for 18 months

    Reflecting the improvement in the general and trophic status of the patient

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • Company EUROS
  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Evaluation of the Efficiency of Nemost Growing Spine Device Associated With Physiotherapy in the Surgical Treatment of Progressive Scoliosis of the Child

Acronym: NEMOST

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Oct 17, 2014
Registry last updated
Sep 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.